Upload Image (Max 20MB per Image)
ScinoPharm and Foresee Pharmaceuticals have signed an agreement to form a joint venture for developing a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug used for treating prostate cancer. ...
Tags: ScinoPharm, Foresee Pharmaceuticals, joint venture